Literature DB >> 24839023

Methods for the study of long noncoding RNA in cancer cell signaling.

Yi Feng1, Xiaowen Hu, Youyou Zhang, Dongmei Zhang, Chunsheng Li, Lin Zhang.   

Abstract

With the advances in sequencing technology and transcriptome analysis, it is estimated that up to 75 % of the human genome is transcribed into RNAs. This finding prompted intensive investigations on the biological functions of noncoding RNAs and led to very exciting discoveries of microRNAs as important players in disease pathogenesis and therapeutic applications. Research on long noncoding RNAs (lncRNAs) is in its infancy, yet a broad spectrum of biological regulations has been attributed to lncRNAs. Here, we provide a collection of detailed experimental protocols for lncRNA studies, including lncRNA immunoprecipitation, lncRNA pull-down, lncRNA northern blot analysis, lncRNA in situ hybridization, and lncRNA knockdown. We hope that the information included in this chapter can speed up research on lncRNAs biology and eventually lead to the development of clinical applications with lncRNA as novel prognostic markers and therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24839023      PMCID: PMC4142042          DOI: 10.1007/978-1-4939-0856-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  51 in total

1.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

2.  YY1 tethers Xist RNA to the inactive X nucleation center.

Authors:  Yesu Jeon; Jeannie T Lee
Journal:  Cell       Date:  2011-07-08       Impact factor: 41.582

3.  Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells.

Authors:  Sabine Loewer; Moran N Cabili; Mitchell Guttman; Yuin-Han Loh; Kelly Thomas; In Hyun Park; Manuel Garber; Matthew Curran; Tamer Onder; Suneet Agarwal; Philip D Manos; Sumon Datta; Eric S Lander; Thorsten M Schlaeger; George Q Daley; John L Rinn
Journal:  Nat Genet       Date:  2010-11-07       Impact factor: 38.330

4.  A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

Authors:  Leonardo Salmena; Laura Poliseno; Yvonne Tay; Lev Kats; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-07-28       Impact factor: 41.582

5.  Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.

Authors:  Y Kotake; T Nakagawa; K Kitagawa; S Suzuki; N Liu; M Kitagawa; Y Xiong
Journal:  Oncogene       Date:  2010-12-13       Impact factor: 9.867

Review 6.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters.

Authors:  Tiffany Hung; Yulei Wang; Michael F Lin; Ashley K Koegel; Yojiro Kotake; Gavin D Grant; Hugo M Horlings; Nilay Shah; Christopher Umbricht; Pei Wang; Yu Wang; Benjamin Kong; Anita Langerød; Anne-Lise Børresen-Dale; Seung K Kim; Marc van de Vijver; Saraswati Sukumar; Michael L Whitfield; Manolis Kellis; Yue Xiong; David J Wong; Howard Y Chang
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

8.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.

Authors:  John R Prensner; Matthew K Iyer; O Alejandro Balbin; Saravana M Dhanasekaran; Qi Cao; J Chad Brenner; Bharathi Laxman; Irfan A Asangani; Catherine S Grasso; Hal D Kominsky; Xuhong Cao; Xiaojun Jing; Xiaoju Wang; Javed Siddiqui; John T Wei; Daniel Robinson; Hari K Iyer; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

9.  lincRNAs act in the circuitry controlling pluripotency and differentiation.

Authors:  Mitchell Guttman; Julie Donaghey; Bryce W Carey; Manuel Garber; Jennifer K Grenier; Glen Munson; Geneva Young; Anne Bergstrom Lucas; Robert Ach; Laurakay Bruhn; Xiaoping Yang; Ido Amit; Alexander Meissner; Aviv Regev; John L Rinn; David E Root; Eric S Lander
Journal:  Nature       Date:  2011-08-28       Impact factor: 49.962

10.  Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.

Authors:  Dong Wang; Ivan Garcia-Bassets; Chris Benner; Wenbo Li; Xue Su; Yiming Zhou; Jinsong Qiu; Wen Liu; Minna U Kaikkonen; Kenneth A Ohgi; Christopher K Glass; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

View more
  23 in total

Review 1.  Lingering Questions about Enhancer RNA and Enhancer Transcription-Coupled Genomic Instability.

Authors:  Gerson Rothschild; Uttiya Basu
Journal:  Trends Genet       Date:  2017-01-10       Impact factor: 11.639

2.  The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer.

Authors:  Yifan Lian; Zhaohua Li; Yanyun Fan; Qingwen Huang; Jianmin Chen; Wenming Liu; Chuanxing Xiao; Hongzhi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Identification of lncRNA-Protein Interactions by CLIP and RNA Pull-Down Assays.

Authors:  Kunming Zhao; Xingwen Wang; Ying Hu
Journal:  Methods Mol Biol       Date:  2021

4.  Identification and activity of the functional complex between hnRNPL and the pseudoexfoliation syndrome-associated lncRNA, LOXL1-AS1.

Authors:  Heather M Schmitt; William M Johnson; Inas F Aboobakar; Shelby Strickland; María Gomez-Caraballo; Megan Parker; Laura Finnegan; David L Corcoran; Nikolai P Skiba; R Rand Allingham; Michael A Hauser; W Daniel Stamer
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

5.  Targeting LncRNAs in Cardiovascular Disease: Options and Expeditions.

Authors:  Stefan Haemmig; Mark W Feinberg
Journal:  Circ Res       Date:  2017-02-17       Impact factor: 17.367

Review 6.  'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.

Authors:  Mei S Ong; Wanpei Cai; Yi Yuan; Hin C Leong; Tuan Z Tan; Asad Mohammad; Ming L You; Frank Arfuso; Boon C Goh; Sudha Warrier; Gautam Sethi; Nicholas S Tolwinski; Peter E Lobie; Celestial T Yap; Shing C Hooi; Ruby Y Huang; Alan P Kumar
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

Review 7.  A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.

Authors:  Sara Malih; Massoud Saidijam; Narges Malih
Journal:  Tumour Biol       Date:  2015-12-11

8.  Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling.

Authors:  Rebecca S DeVaux; Ali S Ropri; Sandra L Grimm; Peter A Hall; Emilio O Herrera; Sridar V Chittur; William P Smith; Cristian Coarfa; Fariba Behbod; Jason I Herschkowitz
Journal:  J Cell Biochem       Date:  2020-01-07       Impact factor: 4.429

9.  Long non‑coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA‑324‑5p and upregulating KCTD20 expression.

Authors:  Jiale Zhang; Yangyang Li; Yuqi Liu; Guangzhi Xu; Yue Hei; Xiaoming Lu; Weiping Liu
Journal:  Oncol Rep       Date:  2021-05-13       Impact factor: 3.906

10.  LncRNA DUXAP10 Upregulation and the Hedgehog Pathway Activation Are Critically Involved in Chronic Cadmium Exposure-Induced Cancer Stem Cell-Like Property.

Authors:  Hsuan-Pei Lin; Zhishan Wang; Chengfeng Yang
Journal:  Toxicol Sci       Date:  2021-10-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.